Biotechvincestanzione

180 views

Published on

However, some wise words of caution from fintrader.net investment guru Vince Stanzione who believes the biotech sector is entering a golden era but warns: “It’s an investors’ dream buying into a small biotech company for a few cents and selling out for many dollars a share.

“It sounds like a fairy tale, and of course that does happen from time to time, but just as the fairy tale recounts ‘you have to kiss a lot of frogs before you find your prince’, my experience of biotech investing is that most companies are over optimistic and results normally take much longer than anticipated if they ever do appear.”

So vet biotech buys as much as you can.

Published in: Economy & Finance
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
180
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Biotechvincestanzione

  1. 1.   However, some wise words of caution from fintrader.net investment guru Vince Stanzionewho believes the biotech sector is entering a golden era but warns: “It’s an investors’ dreambuying into a small biotech company for a few cents and selling out for many dollars a share.“It sounds like a fairy tale, and of course that does happen from time to time, but just as thefairy tale recounts ‘you have to kiss a lot of frogs before you find your prince’, my experienceof biotech investing is that most companies are over optimistic and results normally takemuch longer than anticipated if they ever do appear.”So vet biotech buys as much as you can.  

×